Galderma selects Medidata Rave, mentoring service

Swiss dermatology-product maker Galderma has standardized on the Medidata Rave electronic data capture and clinical data management platform. Medidata says it bested two other CTMS vendors in Galderma's six-month evaluation.

Support for hybrid paper/electronic data studies and multiple language capabilities were key requirements. Another factor was Rave's acceptance by the CRO community, the software maker says.

Galderma runs an R&D operation in France, complemented by development centers in Princeton, NJ, and Tokyo. The treatment maker is using the Rave Knowledge Transfer process, a mentoring and co-development service that Medidata provides to help users tailor the implementation to their needs and abilities and develop in-house the knowledge required to build studies. Training and e-learning tools were another attraction, according to an announcement.

- see the Medidata release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.